J2765
J2765 – Injection, metoclopramide hcl, up to 10 mg · NDC Crosswalk & Billing Units
HCPCS Level II J-code · Medicare Part B drug billing
J-code
● 21 NDCs crosswalked per 10 MG $1.004/unit ASP+6%
📋 J2765 summary
J2765 is a HCPCS Level II J-code used to bill metoclopramide hcl, up to 10 mg, billed per 10 MG. The number of billing units to report depends on the dose administered and the NDC/package billed — use the calculator below.
Brand names associated with J2765: Metoclopramide
Code J2765
Billing unit 10 MG Payment limit $1.004/unit NDC-Crosswalk 21
Quarter Q3 2026
RxCUI Atlas Trace the drug concept →
⚠ An NDC↔HCPCS crosswalk and a published payment limit do not guarantee payer coverage or payment. Always verify the current payer policy and claim format before billing.
🗂️ Key billing facts
HCPCS codeJ2765
DescriptorInjection, metoclopramide hcl, up to 10 mg
Billing unit10 MG
Payment limit / unit$1.004
Est. ASP / unit$0.947 est.
Mapped NDCs21
Data periodQ3 2026
Last updated2026-08-20
💊 About Metoclopramide Injection DRUG GUIDE
Metoclopramide injection is used in adults to relieve symptoms of diabetic gastroparesis (delayed stomach emptying caused by diabetes), to prevent nausea and vomiting from emetogenic cancer chemotherapy (chemotherapy likely to cause vomiting), and to prevent postoperative nausea and vomiting when a stomach tube is not an option.It is also used in both adults and children to help a tube pass into the small bowel during a procedure called small bowel intubation, and in adults to speed up stomach emptying so that radiological (imaging) examinations of the stomach and small intestine can be performed more clearly.
Clinical overview from our editorial drug guide for Metoclopramide Injection. For billing reference, see the sections above.
🧾 Billing & reimbursement HCPCS · CMS · EFF. Q3 2026
📅 Payment limits effective Q3 2026 — from the CMS Medicare Part B Payment Limit File (revised quarterly).
Medicare payment limit / unit
$1.004
Est. ASP / unit
$0.947 est.
Est. after 2% sequester
$0.984
HCPCS dosage
10 MG
The CMS payment limit is the Medicare Part B drug allowance (ASP + 6%, statutory). After the 2% federal sequester the effective payment is ≈ ASP + 4.3%; estimated ASP = payment limit ÷ 1.06. Source: CMS Medicare Part B Payment Limit File (quarterly), Q3 2026.
Full HCPCS code details (official CMS record)
Long descriptionInjection, metoclopramide hcl, up to 10 mg
CoverageD — Special coverage instructions apply
Pricing indicator51 — Drug — priced under the ASP methodology
Type of service1 — Medical care
BETOS-2O1E
ASC payment group—
Action codeN — No maintenance this year
Effective date1997-01-01
Date added1982-01-01
Source: CMS HCPCS Level II code file (imported via admin).
🧮 Dosing & billing-units calculator HCPCS UNITS
One billing unit of J2765 = 10 mg. Enter a regimen to convert dose → billing units and project a full course.
Billing units = dose ÷ HCPCS unit size. Most payers require whole units — round per the payer's policy. “Est. Medicare pay” uses the current payment limit. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (JZ when none is discarded) where allowed. Always verify payer-specific rounding before billing.
🔁 NDCs that bill under J2765 LEAST EXPENSIVE FIRST
21 NDCs map to J2765. Bill units = how many HCPCS units one package represents. Est. pay / pkg = payment limit ($1.004/unit) × that package's bill units.
| NDC (11-digit) | Drug | Labeler | Package | Strength | Bill units | Est. pay / pkg | NADAC / unit | Status | Source |
|---|---|---|---|---|---|---|---|---|---|
| 00409-3414-11 | Metoclopramide 5 mg/mL INJECTION, SOLUTION | Hospira, | 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-3414-... | 5 mg/mL | 25 | $25.10 | $0.529 | ● Active | CMS + PDAC |
| 00409-5255-15 | Metoclopramide 5 mg/mL INJECTION, SOLUTION | Hospira, | 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-5255-... | 5 mg/mL | 25 | $25.10 | $0.529 | ● Active | CMS + PDAC |
| 00703-4502-04 | Metoclopramide 5 mg/mL INJECTION, SOLUTION | Teva | 25 VIAL, SINGLE-USE in 1 TRAY (0703-4502-0... | 5 mg/mL | 25 | $25.10 | $0.529 | ● Active | CMS + PDAC |
| 23155-0240-41 | Metoclopramide 5 mg/mL INJECTION | Heritage | 25 VIAL in 1 CARTON (23155-240-41) / 2 mL... | 5 mg/mL | 25 | $25.10 | $0.529 | ● Active | CMS ASP |
| 83634-0779-02 | Metoclopramide 5 mg/mL INJECTION, SOLUTION | Avenacy, | 25 VIAL, SINGLE-DOSE in 1 CARTON (83634-77... | 5 mg/mL | 25 | $25.10 | $0.529 | ● Active | CMS ASP |
| 00404-9910-02 | Metoclopramide HCl | Henry | — | — | 1 | $1.00 | — | — | CMS ASP |
| 00409-3414-01 | Metoclopramide HCl | Pfizer | — | — | 25 | $25.10 | — | — | CMS ASP |
| 00409-5255-25 | Metoclopramide HCl | Pfizer | — | — | 25 | $25.10 | — | — | CMS + PDAC |
| 00703-4502-93 | Metoclopramide 5 mg/mL INJECTION, SOLUTION | Teva | 10 VIAL, SINGLE-USE in 1 CARTON (0703-4502... | 5 mg/mL | 10 | $10.04 | — | ● Active | CMS + PDAC |
| 51662-1288-01 | METOCLOPRAMIDE 5 mg/mL INJECTION, SOLUTION | HF | 2 mL in 1 VIAL, SINGLE-DOSE (51662-1288-1) | 5 mg/mL | 1 | $1.00 | — | ● Active | CMS ASP |
| 51662-1288-03 | METOCLOPRAMIDE 5 mg/mL INJECTION, SOLUTION | HF | 25 POUCH in 1 CASE (51662-1288-3) / 1 VIA... | 5 mg/mL | 25 | $25.10 | — | ● Active | CMS ASP |
| 76045-0213-20 | Metoclopramide 10 mg/2mL INJECTION, SOLUTION | Fresenius | 24 BLISTER PACK in 1 CARTON (76045-213-20)... | 10 mg/2mL | 24 | $24.10 | — | ● Active | CMS + PDAC |
| 49452-4715-01 | Metoclopramide Hydrochloride 1 g/g CRYSTAL | Spectrum | 10 g in 1 BOTTLE, GLASS (49452-4715-1) | 1 g/g | 100 | $100.40 | — | ● Active | PDAC |
| 51927-1082-00 | METOCLOPRAMIDE HYDROCHLORIDE MONOHYDRATE 1 kg/kg POWDER | Professional | 1 kg in 1 CONTAINER (51927-1082-0) | 1 kg/kg | 100 | $100.40 | — | ● Active | PDAC |
| 51552-0180-03 | METOCLOPRAMIDE HCL MONOHYDRATE (U.S.P.) | Unknown | — | — | 100 | $100.40 | — | — | PDAC |
| 38779-0403-01 | METOCLOPRAMIDE HCL (U.S.P.) | Unknown | — | — | 100 | $100.40 | — | — | PDAC |
| 38779-0403-04 | METOCLOPRAMIDE HCL (U.S.P.) | Unknown | — | — | 100 | $100.40 | — | — | PDAC |
| 38779-0403-05 | METOCLOPRAMIDE HCL (U.S.P.) | Unknown | — | — | 100 | $100.40 | — | — | PDAC |
| 54868-4167-00 | METOCLOPRAMIDE HCL (S.D.V.) 5 MG/ML | Unknown | — | — | 0.5 | $0.50 | — | — | PDAC |
| 62991-2042-02 | METOCLOPRAMIDE HCL (U.S.P.) | Unknown | — | — | 100 | $100.40 | — | — | PDAC |
| 62991-2042-03 | METOCLOPRAMIDE HCL (U.S.P.) | Unknown | — | — | 100 | $100.40 | — | — | PDAC |
NDC→HCPCS mappings come from the CMS ASP NDC-HCPCS crosswalk; additional DME MAC / DMEPOS mappings come from PDAC and are labeled separately. NADAC from CMS (weekly). “Status” reflects the product's marketing / obsolete flag in the NDC directory. Presence or absence here does not determine Medicare coverage. Linked NDCs open the full product page.
📊 Medicare utilization & spend CMS · PART B · 2026 (Q1)
Period
Total Part B spend
$769.16
Claims
585
Beneficiaries
397
Spend / beneficiary
$1.94
Spend / claim
$1.31
Trend by period
Where J2765 ranks among Part B drugs · 2026 (Q1) · neighbors ±5
Total spending — #779 of 824
#774
BUTORPHANOL TARTRATE J0595
$881.00
#775
PHYTONADIONE* J3430
$874.12
#776
AMPICILLIN SODIUM J0290
$832.24
#777
MICAFUNGIN(J2247) J2247
$819.12
#778
DEXTROSE IN WATER(J7... J7070
$808.79
#779
METOCLOPRAMIDE HCL J2765
$769.16
#780
BENZTROPINE MESYLATE J0515
$656.40
#781
CIPROFLOXACIN-D5W J0744
$605.35
#782
PROTAMINE SULFATE J2720
$543.58
#783
METOPROLOL TARTRATE J0616
$528.23
#784
RETACRIT(Q5105) Q5105
$522.38
Total claims — #437 of 824
#432
BICILLIN L-A J0561
610
#433
ADAKVEO J0791
605
#434
VEKLURY J0248
604
#435
BRIUMVI J2329
599
#436
MULTIHANCE MULTIPACK A9578
598
#437
METOCLOPRAMIDE HCL J2765
585
#438
AXTLE J9292
584
#439
HALDOL DECANOATE 100... J1631
573
#440
PEMETREXED DISODIUM(... J9294
568
#441
DEXRAZOXANE J1190
567
#442
TESTOSTERONE ENANTHA... J3121
558
Top Medicare Part B drugs by the selected metric. Click any drug to open its J-code page. Source: CMS Medicare Quarterly Part B Spending by Drug.
Full breakdown by period (2)
| Period | Total spend | Beneficiaries | Claims | $/beneficiary | $/claim |
|---|---|---|---|---|---|
| 2026 (Q1) | $769.16 | 397 | 585 | $1.94 | $1.31 |
| 2025 (Q1-Q4) | $4K | 1,538 | 3,076 | $2.57 | $1.29 |
Provider-administered (Part B) spend, calculated for the whole HCPCS code (CMS does not publish Medicare spend per individual NDC). Self-administered use is covered under Part D instead. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part B Spending by Drug (data.cms.gov), updated quarterly.
📈 Medicare Part B claims detail CMS PSPS · 2024
Calendar-year 2024 Medicare Part B fee-for-service activity for this HCPCS code, summed across all carriers, localities and specialties (CMS Physician/Supplier Procedure Summary). A “service” is one billed line/unit — not one claim — so counts run higher than claim counts.
Allowed charges
$2.7K
Medicare paid
$2.5K
Submitted services
4,316
Denial rate
37.7%
Allowed / service
$1.02
Submitted charges
$68.3K
Source: CMS Physician/Supplier Procedure Summary (PSPS), CY2024 — Medicare Part B carrier + DME fee-for-service claims (excludes Medicare Advantage). Figures are for the whole HCPCS code, which may cover uses beyond this drug. ⚠ CMS hides any figure covering fewer than 11 patients (a privacy rule), so totals — especially denials and low-volume codes — run a little low.
🗺️ Where J2765 is utilized CMS · BY PROVIDER · 2024
Medicare Part B services for this code by the rendering provider's state — 936 services across 4 states & territories in 2024 (CMS reports include DC and U.S. territories). Switch to per 100k to compare states fairly regardless of population. Hover or tap a state for its top ZIP codes.
Hover or tap a state to see its numbers + top ZIP codes.
Per-capita = services ÷ 2023 state population × 100,000 (so high-population states aren't automatically "hotter"). Counts reflect the provider's location, not the patient's. Providers with fewer than 11 patients are hidden by CMS for privacy, so totals run low and per-100k can be noisy in small states — read this as relative geography, not exact counts. Source: CMS Medicare Physician & Other Practitioners — by Provider and Service, 2024.
📊 What bills under J2765
J-codes are billing codes often used for drugs billed under the medical benefit. This connects the billing code to the NDC package records it covers, by ingredient and labeler.
NDC products by ingredient
NDC products by labeler
🗃️ Data sources & freshness
Every figure on this page is computed from public datasets. Here's what each section draws on and how current it is.
HCPCS code & descriptor
CMS HCPCS Level II code file
Loaded
Payment limit & billing unit
CMS Medicare Part B ASP Pricing File (quarterly)
Q3 2026 · as of 2026-08-20
NDC ↔ HCPCS crosswalk
CMS ASP NDC-HCPCS crosswalk + DMEPDAC (PDAC)
21 NDCs mapped
NADAC acquisition cost
CMS National Average Drug Acquisition Cost (weekly)
Available for mapped NDCs
Utilization & spend
CMS Part B Spending by Drug · PSPS · Physician & Other Practitioners
Latest data year 2026
Figures are estimates for reference and may lag the source files. Always verify against the current CMS files and your payer's policy before submitting claims.
⚠️ Practical billing caveats
- A crosswalk is not coverage. An NDC mapping or a published payment limit does not guarantee a payer will cover or pay this code. Check the specific plan's policy.
- Units ≠ milligrams. Bill the number of HCPCS units (dose ÷ the code's unit size), not the milligram dose. Use the calculator above.
- Discarded drug. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (and JZ when nothing is discarded) where the payer allows.
- Rounding & partial units. Many payers require whole units; round per the payer's policy, not automatically up.
- The code can cover more than this drug. Some HCPCS codes span multiple products or strengths — confirm the exact code for the product administered.
- Figures lag. ASP limits change quarterly and utilization data are released with a delay. Verify against the current CMS files before billing.
❓ J2765 billing FAQ
What is HCPCS code J2765?
J2765 is a HCPCS Level II J-code used to bill Injection, metoclopramide hcl, up to 10 mg under Medicare Part B and most medical (not pharmacy) benefits.
What is the billing unit for J2765?
One unit of J2765 represents 10 MG. Report the number of units equal to the dose administered divided by 10 MG.
How many units of J2765 should I bill?
Divide the dose administered by the code's unit size (10 MG) to get the number of billing units, then round per your payer's policy. The calculator on this page converts a dose into billing units and projects a full course.
How much does Medicare pay for J2765?
The Medicare Part B payment limit is $1.004 per unit (Q3 2026), based on ASP + 6%. After the 2% sequester the effective payment is about $0.984 per unit. Payment limits are revised quarterly.
Which NDCs bill under J2765?
21 NDCs currently map to J2765 in the CMS ASP NDC-HCPCS crosswalk. See the NDC crosswalk table above for each product, package, billing units and estimated reimbursement.
Does a crosswalk mean J2765 is covered?
No. An NDC-to-HCPCS crosswalk and a published payment limit do not guarantee coverage or payment. Coverage depends on the payer, the diagnosis and the site of care — always verify the current policy before billing.
For professional billing reference only — verify against the current CMS files before submitting claims.